Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Employees - 20,
CEO - Mr. Eric K. Olson,
Sector - Healthcare,
Country - US,
Market Cap - 6.59M
Altman ZScore(max is 10): -44.53, Piotroski Score(max is 10): 4, Working Capital: $2789000, Total Assets: $9413000, Retained Earnings: $-281738000, EBIT: -10995000, Total Liabilities: $5519000, Revenue: $2537000
- Current Price $2.62 - Analyst Target Price $30.00Ticker | SINT |
Index | - |
Curent Price | 2.62 |
Change | -3.61% |
Market Cap | 6.59M |
Average Volume | 1.33M |
Income | -11.02M |
Sales | 2.89M |
Book Value/Share | 2.90 |
Cash/Share | 1.43 |
Dividend Est | - |
Dividend TTM | - |
Dividend Ex-Date | - |
Employees | 20 |
Moving Avg 20days | 20.96% |
Moving Avg 50days | -11.81% |
Moving Avg 200days | -25.21% |
Shares Outstanding | 2.52M |
Earnings Date | Mar 24 |
Inst. Ownership | 1.56% |
Price/Earnings | - |
Forwad P/E | - |
PE Growth | - |
Price/Sales | 2.28 |
Price/Book | 0.90 |
Price/Cash | 1.83 |
Price/FCF | - |
Quick Ratio | 2.15 |
Current Ratio | 2.41 |
Debt/Equity | 1.04 |
Return on Assets | -88.98% |
Return on Equity | -174.07% |
Return on Investment | -148.35% |
Gross Margin | 23.97% |
Ops Margin | -313.06% |
Profit Margin | -381.85% |
RSI | 55.87 |
BETA(β) | 0.81 |
From 52week Low | 53.33% |
From 52week High | -94.25% |
EPS | -22.09 |
EPS next Year | -2.02 |
EPS next Qtr | -0.76 |
EPS this Year | 81.72% |
EPS next 5 Year | - |
EPS past 5 Year | 83.21% |
Sales past 5 Year | 44.80% |
EPS Y/Y | 94.56% |
Sales Y/Y | 9.90% |
EPS Q/Q | 98.80% |
Sales Q/Q | -39.91% |
Sales Surprise | -3.87% |
EPS Surprise | 5.00% |
ATR(14) | 0.28 |
Perf Week | 49.82% |
Perf Month | -10.52% |
Perf Quarter | -18.32% |
Perf Year | -63.38% |
Perf YTD | -25.09% |
Target Price | 30.00 |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer